AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
via FOX BUSINESS NEWS Markets
https://ift.tt/3qRCabi
0 comments:
Post a Comment